Nitric Oxide
Back to searchMolecule Structure
Scientific Name
Nitric Oxide
Description of the Drug
Nitric Oxide is a vasodilating agent used in the treatment of hypoxic respiratory failure in premature neonates.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00435
http://www.drugbank.ca/drugs/DB00435
Brand Name(s)
Genosyl, Inomax
Company Owner(s)
Mallinckrodt Hosp Products Ip Ltd, Linde Gas And Equipment Inc, Vero Biotech
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Soluble guanylate cyclase | PROTEIN COMPLEX GROUP | ACTIVATOR | CHEMBL2111348 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7560 | |
| PharmGKB | PA450635 | |
| Human Metabolome Database | HMDB0003378 | |
| DrugBank | DB00435 | |
| PubChem: Thomson Pharma | 15170299 | |
| PubChem | 145068 | |
| NMRShiftDB | 60020387 | |
| Nikkaji | J415.432K | J1.313.254B |
| EPA CompTox Dashboard | DTXSID1020938 | |
| DrugCentral | 1948 | |
| Metabolights | MTBLC16480 | |
| Rhea | 16480 | |
| ChemicalBook | CB5433122 | |
| rxnorm | NITRIC OXIDE | INOMAX |
| KEGG Ligand | C00533 | |
| ChEBI | 16480 |
